 SAN DIEGO, Nov. 3, 2021 PRNewswire -- Regulus Therapeutics Inc. Nasdaq: RGLS, a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs the Company or Regulus, today announced that it will report financial results and highlights for the quarter ended September 30, 2021 on Wednesday, November 10, 2021, after the U.S. financial markets close. The Company will host a conference call and live audio webcast on Wednesday, November 10, 2021 at 5:00 p.m. 